Post

New research · Urology
Lower urinary tract symptoms · 1d
Meta-analysisLower urinary tract symptoms · 2026

Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

Shugo Yajima, Soichiro Yoshida, Wei Chen … Yasuhisa Fujii
Read paper
UrologyMeta-analysis

Monopolar transurethral resection of the prostate is preferred for urodynamic outcomes.

Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

Shugo Yajima et al. · Lower urinary tract symptoms · 2026
Purpose

To compare minimally invasive surgical therapies (MISTs) for benign prostatic obstruction (BPO) using probabilistic multicriteria decision analysis that integrates heterogeneous clinical outcomes under varying stakeholder priorities.

Methods

This secondary analysis was derived from a published network meta-analysis.

Results

Monopolar transurethral resection of the prostate had an 88.0% probability of being best for efficacy.

net advantage 0.12 (95% CI 0.03 to 0.21)
null 0
0.03
0.21
CI excludes the null - significant
More results

Under equal weights, WVTT had the highest P(best) (54.1%), followed by mTURP (25.8%) and PUL (20.1%); all pairwise UIs crossed zero.

Under sexual function weights, mTURP was rarely preferred (P[best] < 0.1%), whereas PUL and WVTT achieved P(best) of 45.3% and 54.7%, respectively.

More results

Rankings were robust in both anchor perturbation and correlation sensitivity analyses.

“
Conclusion · 1 of 2

Within short-term (3-6 month) data, MIST preference for BPO depends on clinical priorities. mTURP is favored when urodynamic outcomes are emphasized; PUL and WVTT are preferred when preservation of sexual function is prioritized.

Conclusion · 2 of 2

This framework supports preference-sensitive shared decision-making, although the findings are provisional pending long-term data.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
HR 1.87
lower muscle quality means nearly twice the risk of dying from advanced prostate cancer
Cross-sectional
71.8%
most urologists never used a standard survey to assess stent symptoms
Cohort Study
SIR 1.67
young bladder cancer survivors have a higher risk of developing second cancers compared to the general population
Cohort Study
98%
98% of patients had no significant rectocele after laparoscopic double sacrocolpopexy.
Cohort Study
OR 0.10
Beyond 4000 J/ml, the odds of reintervention are 90% lower.
Randomized Trial
hazard ratio 0·67
pirarubicin instillation led to a lower risk of recurrence compared to observation
Study
3,216
This many specific enhancers were found in prostate cancer cells, not normal cells.
Case-control
OR = 4.23
Higher triglycerides linked to higher odds of prostate cancer (odds, not risk)